Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/29/2007WO2007075827A3 Homogeneous paste formulations
11/29/2007WO2007074346A3 Modulation of wnt signalling pathways for treating nervous system disorders
11/29/2007WO2007073888A3 Pharmaceutical composition containing donepezil hydrochloride, tablets produced therefrom and method for producing the same
11/29/2007WO2007070302A3 Process for preparing conjugated linoleic acid and derivatives thereof from ricinoleic acid
11/29/2007WO2007065010A3 Anti-angiogenesis compounds
11/29/2007WO2007064795A3 Purine derivatives and methods of use thereof
11/29/2007WO2007064753A3 Cancer treatment method
11/29/2007WO2007062337A3 Crystalline forms
11/29/2007WO2007062335A3 New pleuromutilin derivative and its use
11/29/2007WO2007062118A3 Glycerol levulinate ketals and their use
11/29/2007WO2007062067A3 Chemical compounds
11/29/2007WO2007061692A3 Spirolactam tricyclic cgrp receptor antagonists
11/29/2007WO2007059341A3 Pyrazolothiazole protein kinase modulators
11/29/2007WO2007056454A3 Use of cicletanine and other furopyridines for treatment of hypertension
11/29/2007WO2007056324A3 Combination of an angiotensin ii receptor blocker, a calcium channel blocker and another active agent
11/29/2007WO2007056214A3 N-alkyl-n-aryl-thienopyrimidin-r-amines and uses thereof
11/29/2007WO2007056143A3 Certain chemical entities, compositions, and methods
11/29/2007WO2007053796A3 Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropion
11/29/2007WO2007053794A3 Functionalized phenolic compounds and absorbable therefrom
11/29/2007WO2007053641A3 A-type procyanidins and inflammation
11/29/2007WO2007053610A3 Methods of treating atrial fibrillation wtih pirfenidone
11/29/2007WO2007053197A3 Nanoparticulate acetaminophen formulations
11/29/2007WO2007050587A3 Therapeutic compositions and methods
11/29/2007WO2007041584A3 Implantable sensors, implantable pumps, and anti-scarring drug combinations
11/29/2007WO2007041367A3 Oral composition containing a salivation inducing agent
11/29/2007WO2007039784A3 A novel crystalline polymorph of fluvastatin sodium and process for preparing it
11/29/2007WO2007038512A3 Phosphate prodrugs of a farnesyl dibenzodiazepinone, processes for their production and their use as pharmaceuticals
11/29/2007WO2007038453A3 Use of an anti-vascular endothelial growth factor (vegf) agent to ameliorate inflammation
11/29/2007WO2007035722A8 Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
11/29/2007WO2007027248A3 3', 5' - cyclic nucleoside analogues for treatment of hcv
11/29/2007WO2007023389B1 Polymorphic forms of 3-amino-1-propanesulfonic acid
11/29/2007WO2007019550A3 Composition and method for use in cartilage affecting conditions
11/29/2007WO2007017144A3 Macrocylic inhibitors of hepatitis c virus
11/29/2007WO2007014927A3 Macrocyclic inhibitors of hepatitis c virus
11/29/2007WO2007014619A8 Novelimidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
11/29/2007WO2007014247A3 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
11/29/2007WO2006130844A3 Fucoidan delivery system
11/29/2007WO2006128659A3 Piperazine derivative renin inhibitors.
11/29/2007WO2006115770A3 Orally disintegrating pharmaceutical tablet formulations of olanzapine
11/29/2007WO2006107311A3 Biocompatible polymeric vesicles self assembled from triblock copolymers
11/29/2007WO2006106326A8 Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors
11/29/2007WO2006095159A8 (imidazolo-5-yl)-2-anilo-pyrimidines as agents for the inhibition of cell proliferation
11/29/2007WO2006079539A3 Use of pyrimidylaminobenzamides for the treatment of diseases that respond to modulation of tie-2 kinase activity
11/29/2007WO2006072612A3 Triazolophthalazines as pde2- inhibitors
11/29/2007WO2006050075A3 Method of increasing efficacy of tumor cell killing using combinations of anti-neoplastic agents
11/29/2007WO2006047392A3 Nicotinic-opioid synergy for analgesia
11/29/2007WO2005044196A3 Novel modulators of amyloid-beta production and uses thereof
11/29/2007WO2005009352A3 Antimicrobial compositons containing synergistic combinations of quaternary ammonium compounds and essential oils and/or constituents thereof
11/29/2007WO2004113496A3 Double stranded compositions comprising a 3’-endo modified strand for use in gene modulation
11/29/2007WO2004006852A3 Method for selectively inhibiting fungal growth
11/29/2007WO2002028345A3 Aldehyde-releasing compounds
11/29/2007US20070276147 Synthesis of Oligomeric Epicatechin- and Catechin-Derived Procyanidins
11/29/2007US20070276141 Preparation of Pharmaceutical Salts of [1,4] - Bipiperidine
11/29/2007US20070276140 Chiral 1,8-Diarylnaphthalenes, Methods of Making Them, and Their Use as Sensors
11/29/2007US20070276138 Modulators of peroxisome proliferator activated receptors
11/29/2007US20070276050 Methods for identifying ASK1 inhibitors useful for preventing and/or treating cardiovascular diseases
11/29/2007US20070276049 Inhibiting cell membrane-mediated effects of infectious microorganisms using a family of glycerol-based compounds such as glycerol monolaurate (GML)
11/29/2007US20070276048 Unit dose formulations comprising an inhalable solution of albuterol
11/29/2007US20070276047 Modified release formulations of a bupropion salt
11/29/2007US20070276046 Alpha-Aminoamide Derivatives Useful as Anti-Inflammatory Agents
11/29/2007US20070276045 Anti-Bacterial Compounds
11/29/2007US20070276044 Peeling Cosmetic Method Using a 8-Hexadecene-1,16-Dicarboxylic Acid
11/29/2007US20070276043 3-(p-Substituted alkoxyphenyl)-2-(o-benzoylanilino)propionic acid derivatives, e.g., 2-(o-Benzoylphenylamino)-3-(p-{2-[(o-fluorophenyl)isobutylamino]-ethoxy}phenyl)propionic acid; for treating non-insulin dependent diabetes and obesity
11/29/2007US20070276042 Preparation and utility of substituted carboxylic acid compounds
11/29/2007US20070276041 Ppar activity regulators
11/29/2007US20070276040 Peptidyl Arginine Deiminase Type IV Inhibitor
11/29/2007US20070276039 Pharmaceutical uses for alpha2delta ligands
11/29/2007US20070276037 Cytoprotective Effects of Ethyl Pyruvate
11/29/2007US20070276036 Non-Glycosidic and Non-Peptidic Select Inhibitors, and the Use Thereof
11/29/2007US20070276035 Treatment of neurotic disorders
11/29/2007US20070276034 Compounds, compositions and methods for the treatment of synucleinopathies
11/29/2007US20070276033 ascorbic acid compositions that stabilize unusually large concentrations of vitamin C and vitamin E
11/29/2007US20070276032 Use of 8-Prenylnaringenin for Hormone Replacement Therapy
11/29/2007US20070276031 Process for Purifying (-)- 9-Trans-Tetrahydrocannabinol
11/29/2007US20070276030 Pyranobenzothiophene derivatives to treat infection with hepatitis c virus
11/29/2007US20070276029 Glutamine-Containing Energy Imparting Amino Acid Composition or Amino Acid Solution
11/29/2007US20070276026 Hydroxybenzamide Derivatives And Their Use As Inhibitors Of HSP90
11/29/2007US20070276025 Indirubin-Type Compounds, Compositions, and Methods for Their Use
11/29/2007US20070276024 Methods for Treating Diseases and Conditions with Inverse Agonists and for Screening for Agents Acting as Inverse Agonists
11/29/2007US20070276022 Optically Active Carboxamides
11/29/2007US20070276021 Method for treatment of neurodegenerative disorders
11/29/2007US20070276020 Dicationic Compounds For Activity Against Trichomonas Vaginalis
11/29/2007US20070276019 Haloalkyl Containing Compounds as Cysteine Protease Inhibitors
11/29/2007US20070276018 Aziridinyl-epothilone compounds
11/29/2007US20070276017 Thiadiazoline Derivative
11/29/2007US20070276016 Cholecystokinin (CCK2) receptor modulators; e.g. 2-(Benzo[1,2,5]thiadiazole-4sulfonylamino)-4-fluoro-N-[1-(4-fluoro-phenyl)-ethyl]-N-methyl-benzamide; pancreatic adenocarcinoma, pain, eating disorders, gastro-esophageal reflux disease, ulcers, anxiety
11/29/2007US20070276015 Crystal modification of torasemide
11/29/2007US20070276012 Process for Preparing Thiazolidinediones
11/29/2007US20070276011 Plasminogen Activator Inhibitor-1 Inhibitor
11/29/2007US20070276010 benzyl-carbamic acid cis-3-[5-(cyclohexanecarbonyl-amino)-1H-pyrazol-3-yl]-cyclobutyl ester; glycogen synthase kinase-3 (GSK-3) inhibitors; inter alia, Alzheimer's Disease, cancer, dementia, depression, diabetes, hair loss, schizophrenia, and stroke
11/29/2007US20070276009 Compositions and Methods for Viral Inhibition
11/29/2007US20070276008 Pharmaceutical formulation comprising glycine as a stabilizer
11/29/2007US20070276007 Administration of pharmaceuticals
11/29/2007US20070276006 Method for the treatment of gastrointestinal disorders
11/29/2007US20070276005 Tri-substitued 2-benzhydryl 5-benzlamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6 disubstituted pyran derivatives
11/29/2007US20070276004 Pharmaceutical Composition Comprising an Immunosuppressant for Use in the Treatment of Skin Diseases
11/29/2007US20070276003 Biphenyl-2-ylcarbamic acid 1-{7-[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]heptyl}piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist; bronchodilator agent; pulmonary disorders, chronic obstructive pulmonary disease and asthma
11/29/2007US20070276002 Compounds and Compositions as Channel Activating Protease Inhibitors
11/29/2007US20070276001 Biphenyl-pyrazolecarboxamide compounds
11/29/2007US20070276000 (2E)-3-[4-[(6-hydroxy-3-methyl-2-phenyl-1-naphthalenyl)oxy]-2-(trifluoromethyl)phenyl]-2-propenoic acid; menopausal or postmenopausal disorders, vasomotor symptoms, vaginal atrophy, atrophic vaginitis, endometriosis, female sexual dysfunction, breast cancer, depression, diabetes, osteoporosis
1 ... 3480 3481 3482 3483 3484 3485 3486 3487 3488 3489 3490 3491 3492 3493 3494 3495 3496 3497 3498 3499 3500 ... 7860